ArticleNPJ precision oncology2025

Ex vivo 3D micro-tumour testing platform for predicting clinical response to platinum-based therapy in patients with high-grade serous ovarian cancer.

Esmee Koedoot et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.